Clinical Trial: Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Mitiperstat
Brief Summary:
This study will assess the effect of hepatic impairment on the pharmacokinetics (PK), safety and tolerability of mitiperstat.
Read more